"Visit the UCLA Health website for coronavirus updates."

During the past decade, Doheny Eye Center UCLA conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Doheny Eye Center UCLA" #1 sponsor was "GenSight Biologics" with 3 trials, followed by "Doheny Image Reading Center" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "IVERIC bio, Inc." with 1 trials sponsored and "Immunovant Sciences GmbH" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Doheny Eye Center UCLA" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Doheny Eye Center UCLA" are "Leber Hereditary Optic Neuropathy" (3 trials), "Geographic Atrophy" (2 trials), "Age-related Macular Degeneration (AMD)" (1 trials), "Glaucoma" (1 trials) and "Glaucoma, Angle-closure, Primary, Acute" (1 trials). Many other conditions were trialed in "Doheny Eye Center UCLA" in a lesser frequency.

Most popular intervention types in "Doheny Eye Center UCLA" are "Drug" (6 trials), "Other" (6 trials), "Device" (2 trials), "Genetic" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "GS010" (2 trials), "Sham" (2 trials), "(including placebo)" (1 trials), "0.67% Sodium Chloride Ophthalmic Solution" (1 trials) and "APL-2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Doheny Eye Center UCLA" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Doheny Eye Center UCLA". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Doheny Eye Center UCLA, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Doheny Eye Center UCLA, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".